Transobturator (TOR) showed no clear difference in subjective cure (Short term < 1 year) compared with retropubic (RPR) route (moderate certainty).
Transobturator (TOR) showed no clear difference in repeat incontinence surgery (short term, within 12 months) compared with retropubic (RPR) route (moderate certainty).
Transobturator (TOR) showed no clear difference in subjective cure (medium term, 1 to 5 years) compared with retropubic (RPR) route (low certainty).
Transobturator (TOR) showed no clear difference in subjective cure (long term, > 5 years) compared with retropubic (RPR) route (moderate certainty).
Transobturator (TOR) probably leads to lower bladder or urethral perforation compared with retropubic (RPR) route (moderate certainty).
Transobturator (TOR) probably leads to lower voiding dysfunction (short and medium term, up to 5 years) compared with retropubic (RPR) route (moderate certainty).
Transobturator (TOR) showed no clear difference in de novo urgency or urgency incontinence (short term, up to 12 months) compared with retropubic (RPR) route (moderate certainty).
Transobturator (TOR) probably leads to higher groin pain compared with retropubic (RPR) route (moderate certainty).
Transobturator (TOR) probably leads to lower suprapubic pain compared with retropubic (RPR) route (moderate certainty).
Transobturator (TOR) showed no clear difference in vaginal tape erosion (short and medium term, up to 5 years) compared with retropubic (RPR) route (moderate certainty).
Single‐incision slings showed no clear difference in subjective cure or improvement of urinary incontinence: 12 months compared with transobturator minimally‐invasive slings (high certainty).
Single‐incision slings probably leads to lower patient‐reported pain: at more than 24 months compared with transobturator minimally‐invasive slings (moderate certainty).
Single‐incision slings showed no clear difference in number of women with dyspareunia compared with transobturator minimally‐invasive slings (moderate certainty).
Single‐incision slings leads to lower number of women with mesh exposure, extrusion or erosion in any area compared with transobturator minimally‐invasive slings (high certainty).
Single‐incision slings probably leads to lower number of women with urinary retention compared with transobturator minimally‐invasive slings (moderate certainty).
Single‐incision slings may leads to higher quality of life: at 12 months compared with transobturator minimally‐invasive slings (low certainty).
Single‐incision slings showed no clear difference in number of women requiring repeat continence surgery or mesh revision compared with transobturator minimally‐invasive slings (low certainty).